Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

DOP031: Individualized home-monitoring of disease activity in adult patients with Inflammatory Bowel Disease can be recommended implemented in clinical practiceECCO'18 Vienna
Year: 2018
Authors: Ankersen Dorit Vedel
Files: 1
DOP032: Crohn’s Disease patients’ perspectives towards de-escalating immunosuppressive therapy: A comparative French and American surveyECCO'18 Vienna
Year: 2018
Authors: Siegel Corey A.
Files: 1
DOP033: Trends in epidemiology of Inflammatory Bowel Disease among Jewish Israeli adolescents: A population based studyECCO'18 Vienna
Year: 2018
Authors: Ghersin Itai
Files: 1
DOP034: Assessment of direct healthcare cost drivers of Crohn's Disease in a Dutch population-based cohort study shows a major shiftECCO'18 Vienna
Year: 2018
Authors: Lalisang Robbert
Files: 1
DOP036: Ustekinumab for Crohn's Disease: A nationwide real-life observational cohort study (ICC Case Series)ECCO'18 Vienna
Year: 2018
Authors: Biemans Vince
Files: 1
DOP037: Postoperative anti-TNF therapy is associated with a significant reduction of both endoscopic and clinical recurrence following surgery for ileocolonic Crohn's Disease: Results of a prospective nationwide cohort conducted by the GETAID chirurgie groupECCO'18 Vienna
Year: 2018
Authors: Maggiori Léon
Files: 1
DOP038: Postoperative outcome in 2890 patients following right hemicolectomy and ileo-cecal resection in colonic cancer and Crohn’s Disease: Results from ESCP-SECCO snapshot prospective audit 2015ECCO'18 Vienna
Year: 2018
Authors: Dich Grandt Sanne
Files: 1
DOP039: Exploring stoma rates in Crohn’s Disease in the biologic era: A population-based time trend analysisECCO'18 Vienna
Year: 2018
Authors: Ma Christopher
Files: 1
DOP040: Five-year colectomy data from the Observational Postmarketing Ulcerative Colitis Study, a European registry for adults with Ulcerative Colitis treated with originator infliximab or conventional therapyECCO'18 Vienna
Year: 2018
Authors: Panés Julián
Files: 1
DOP041: Surgery and hospitalisation in patients with Inflammatory Bowel Disease; 10 years follow-up of a Danish population-based inception cohortECCO'18 Vienna
Year: 2018
Authors: Lo Bobby
Files: 1
DOP042: Need for ileocaecal resections, but not ileo-colic re-resections, has decreased – a nationwide study of temporal trends in Crohn surgery in Sweden 1990-2014ECCO'18 Vienna
Year: 2018
Authors: Kalman Disa
Files: 1
DOP043: Comparative outcomes of ileal pouch revision vs. excision for pouch failure within the American College of Surgeon National Surgical Quality Improvement ProgrammeECCO'18 Vienna
Year: 2018
Authors: Holubar Stefan
Files: 1
DOP044: Efficacy, safety and long-term outcome of endoscopic dilation therapy for Crohn’s Disease strictures of the upper gastrointestinal tract – an international multicentre cohort study including 99 patients with 129 dilation proceduresECCO'18 Vienna
Year: 2018
Authors: Bettenworth Dominik
Files: 1
DOP045: Combination therapy with anti-TNF and immunosuppressive therapies is the most effective medication to prevent and treat endoscopic postoperative recurrence in patients with Crohn’s DiseaseECCO'18 Vienna
Year: 2018
Authors: Buisson Anthony
Files: 1
DOP048: Vedolizumab levels during induction are associated with long-term clinical and endoscopic remission in patients with Inflammatory Bowel DiseaseECCO'18 Vienna
Year: 2018
Authors: Yarur Andres
Files: 1
DOP049: Combination therapy of cyclosporine and vedolizumab is effective and safe for severe, steroid-resistant Ulcerative Colitis patients: A prospective studyECCO'18 Vienna
Year: 2018
Authors: Tarabar Dino
Files: 1
DOP050: Influence of disease location on vedolizumab efficacy in Inflammatory Bowel Disease: A real-life multicentre experienceECCO'18 Vienna
Year: 2018
Authors: Pestour Sandie
Files: 1
DOP051: Shorter disease duration is associated with higher response rates to vedolizumab in Crohn’s Disease but not Ulcerative Colitis: A multi-centre consortium analysisECCO'18 Vienna
Year: 2018
Authors: Dulai Parambir S
Files: 1
DOP052: Vedolizumab versus ustekinumab for Crohn's Disease: Comparative effectiveness in a real-life observational cohort study (ICC Case Series)ECCO'18 Vienna
Year: 2018
Authors: Biemans Vince
Files: 1
DOP053: Impact of concomitant immunomodulator use on vedolizumab effectiveness: A multicentre consortium propensity score–matched analysisECCO'18 Vienna
Year: 2018
Authors: Dulai Parambir S
Files: 1